RHÖN-KLINIKUM AG
- WKN: 704230
- ISIN: DE0007042301
- Land: Deutschland
Nachricht vom 02.05.2012 | 17:00
RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
RHÖN-KLINIKUM AG
02.05.2012 17:00
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Publication according to sec. 26 paragraph 1 sentence 1 WpHG
1.) Notification of voting rights pursuant to sec. 25a paragraph 1 WpHG
Else Kröner-Fresenius-Stiftung, Bad Homburg v. d. Höhe, Germany, notified
us on 27 April 2012 pursuant to sec. 25a paragraph 1 WpHG of the following:
1. Listed Company: RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616
Bad Neustadt a. d. Saale, Germany
2. Notifier: Else Kröner-Fresenius-Stiftung, Bad Homburg v. d. Höhe,
Germany
3. Triggering event: Exceeding threshold following acquisition
4. Threshold(s) crossed or reached: 5 %, 10 %
5. Date at which the threshold was crossed or reached: 25 April 2012
6. Total amount of voting rights: 12.45 % (equals 17,214,727 voting rights)
Calculated from the following total number of voting rights issued:
138,232,000
7. Detailed information on the voting rights proportion:
Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG: 12.45 % (equals 17,214,727 voting rights)
Thereof held indirectly: 12.45 % (equals 17,214,727 voting rights)
8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:
Chain of controlled undertakings: Fresenius Management SE; Fresenius SE &
Co. KGaA; Fresenius ProServe GmbH; FPS Beteiligungs AG
Name/description of the financial/other instrument: Irrevocable undertaking
2.) Notification of voting rights pursuant to sec. 25a paragraph 1 WpHG
Fresenius Management SE, Bad Homburg v. d. Höhe, Germany, notified us on 27
April 2012 pursuant to sec. 25a paragraph 1 WpHG of the following:
1. Listed Company: RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616
Bad Neustadt a. d. Saale, Germany
2. Notifier: Fresenius Management SE, Bad Homburg v. d. Höhe, Germany
3. Triggering event: Exceeding threshold following acquisition
4. Threshold(s) crossed or reached: 5 %, 10 %
5. Date at which the threshold was crossed or reached: 25 April 2012
6. Total amount of voting rights: 12.45 % (equals 17,214,727 voting rights)
Calculated from the following total number of voting rights issued:
138,232,000
7. Detailed information on the voting rights proportion:
Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG: 12.45 % (equals 17,214,727 voting rights)
Thereof held indirectly: 12.45 % (equals 17,214,727 voting rights)
8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:
Chain of controlled undertakings: Fresenius SE & Co. KGaA; Fresenius
ProServe GmbH; FPS Beteiligungs AG
Name/description of the financial/other instrument: Irrevocable undertaking
3.) Notification of voting rights pursuant to sec. 25a paragraph 1 WpHG
Fresenius SE & Co. KGaA, Bad Homburg v. d. Höhe, Germany, notified us on 27
April 2012 pursuant to sec. 25a paragraph 1 WpHG of the following:
1. Listed Company: RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616
Bad Neustadt a. d. Saale, Germany
2. Notifier: Fresenius SE & Co. KGaA, Bad Homburg v. d. Höhe, Germany
3. Triggering event: Exceeding threshold following acquisition
4. Threshold(s) crossed or reached: 5 %, 10 %
5. Date at which the threshold was crossed or reached: 25 April 2012
6. Total amount of voting rights: 12.45 % (equals 17,214,727 voting rights)
Calculated from the following total number of voting rights issued:
138,232,000
7. Detailed information on the voting rights proportion:
Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG: 12.45 % (equals 17,214,727 voting rights)
Thereof held indirectly: 12.45 % (equals 17,214,727 voting rights)
8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:
Chain of controlled undertakings: Fresenius ProServe GmbH; FPS Beteiligungs
AG
Name/description of the financial/other instrument: Irrevocable undertaking
4.) Notification of voting rights pursuant to sec. 25a paragraph 1 WpHG
Fresenius ProServe GmbH, Bad Homburg v. d. Höhe, Germany, notified us on 27
April 2012 pursuant to sec. 25a paragraph 1 WpHG of the following:
1. Listed Company: RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616
Bad Neustadt a. d. Saale, Germany
2. Notifier: Fresenius ProServe GmbH, Bad Homburg v. d. Höhe, Germany
3. Triggering event: Exceeding threshold following acquisition
4. Threshold(s) crossed or reached: 5 %, 10 %
5. Date at which the threshold was crossed or reached: 25 April 2012
6. Total amount of voting rights: 12.45 % (equals 17,214,727 voting rights)
Calculated from the following total number of voting rights issued:
138,232,000
7. Detailed information on the voting rights proportion:
Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG: 12.45 % (equals 17,214,727 voting rights)
Thereof held indirectly: 12.45 % (equals 17,214,727 voting rights)
8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:
Chain of controlled undertakings: FPS Beteiligungs AG
Name/description of the financial/other instrument: Irrevocable undertaking
5.) Notification of voting rights pursuant to sec. 25a paragraph 1 WpHG
FPS Beteiligungs AG, Düsseldorf, Germany, notified us on 27 April 2012
pursuant to sec. 25a paragraph 1 WpHG of the following:
1. Listed Company: RHÖN-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616
Bad Neustadt a. d. Saale, Germany
2. Notifier: FPS Beteiligungs AG, Düsseldorf, Germany
3. Triggering event: Exceeding threshold following acquisition
4. Threshold(s) crossed or reached: 5 %, 10 %
5. Date at which the threshold was crossed or reached: 25 April 2012
6. Total amount of voting rights: 12.45 % (equals 17,214,727 voting rights)
Calculated from the following total number of voting rights issued:
138,232,000
7. Detailed information on the voting rights proportion:
Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG: 12.45 % (equals 17,214,727 voting rights)
8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:
Name/description of the financial/other instrument: Irrevocable undertaking
Bad Neustadt/Saale, 2 May 2012
The Board of Management
________________________________________________________________________
Dr. Kai Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: 09771 65 - 1318
Telefax: 09771 99 - 1736
02.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Weitere News
-
10.05.13 09:49
RHÖN-KLINIKUM AG: Shareholder Alecta demands a ... -
03.05.13 15:10
RHÖN-KLINIKUM Aktiengesellschaft: Bekanntmachu ... -
25.04.13 07:00
RHÖN-KLINIKUM AG: Accounts press conference in ... -
10.04.13 11:57
RHÖN-KLINIKUM AG: Announcement according to Ar ... -
21.02.13 07:00
RHÖN-KLINIKUM AG: preliminary results for the ...
Anleihe im Fokus
7,75% p.a. - Rendite aus Familienhand
– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs
GBC-Fokusbox
Syzygy AG: Aktie kaufen
Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.
Der AKTIONÄR News

21. Mai 19:25 400-Prozent-Aktie: Spekulationen um Apple
21. Mai 16:45 DAX schafft erneut die Wende: Bayer, Commerzbank, Continental, ...
21. Mai 15:17 Commerzbank: Staatsbeteiligung sinkt drastisch
21. Mai 14:35 Trading-Chance bei Telegate: 22 Prozent Dividendenrendite sorgen für ...
21. Mai 14:25 46 Prozent in vier Monaten: Schrei-vor-Glück-Aktie ist nicht zu ...
Aktuelle Research-Studie

Orad Hi-Tec Systems Ltd
Original-Research: Orad Hi Tec Systems (von VEM Aktienbank AG): Kaufen
21. Mai 2013
